Assessment issues and the cost of schizophrenia.

Assessment issues and the cost of schizophrenia.

Item
http://www.wikidata.org/entity/Q37499928
Quetiapine versus other atypical antipsychotics for schizophreniaPerspective from an NGO.A community-based perspective.Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs.Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models.Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.Burden of care among relatives of patients with schizophrenia in midwestern Nigeria.Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation.Health care costs of therapy-refractory schizophrenic patients treated with clozapine: a study in a community psychiatric service in Italy.Costs of services for schizophrenic patients in Norway.
P2860

Assessment issues and the cost of schizophrenia.

Item
http://www.wikidata.org/entity/Q37499928
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment issues and the cost of schizophrenia.
@en
Assessment issues and the cost of schizophrenia.
@nl
type
label
Assessment issues and the cost of schizophrenia.
@en
Assessment issues and the cost of schizophrenia.
@nl
prefLabel
Assessment issues and the cost of schizophrenia.
@en
Assessment issues and the cost of schizophrenia.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Assessment issues and the cost of schizophrenia.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921